Clinical Research
Mass Spectrometric Immunoassay (MSIA)
SimulTOF Systems is engaged in biomarker discovery and clinical research assay development though a collaboration with the Laboratory of Dr. Randall Nelson (The Biodesign Institute, Arizona State University, Tempe, AZ.). Current initiatives are aimed at leveraging the high-performance and speed of SimulTOF Systems MALDI-TOF mass spectrometers with the immune-affinity purification array technology developed at Arizona State University.
The analyte selectivity and parallel sample processing offered by immune-affinity purification arrays coupled with the speed, sensitivity and accuracy (over a broad mass range) offered by SimulTOF Systems mass spectrometers, will enable large-scale research investigations designed to more fully understand the distribution and characteristics of full-length proteins in relation to health and disease.